The use of eardrops in an ENT department

Pharmacy World and Science

Volumn 21, Issue 6, 1999, Pages 266-269

  Natsch, S ^b   Mylanus, E A M ^b   Mulder, J J S ^b   Hekster, Y A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Drug utilisation review; Ear diseases; Ear drops; Otitis

Indexed keywords

ACETIC ACID; BACITRACIN; COLISTIN; CRYSTAL VIOLET; DEXAMETHASONE; EAR DROPS; FLUMETASONE; FRAMYCETIN; GRAMICIDIN; HYDROCORTISONE; MICONAZOLE; NEOMYCIN; OFLOXACIN; OXYTETRACYCLINE; POLYMYXIN; TRIAMCINOLONE ACETONIDE;

ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; DRUG CONTRAINDICATION; DRUG SAFETY; DRUG USE; EAR INFECTION; EARDRUM PERFORATION; HUMAN; MAJOR CLINICAL STUDY; OTITIS; OTOTOXICITY; PRACTICE GUIDELINE;

ADMINISTRATION, TOPICAL; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; BACTERIAL INFECTIONS; DRUG UTILIZATION; EAR; EAR DISEASES; HOSPITAL DEPARTMENTS; HUMANS; NETHERLANDS; OUTPATIENT CLINICS, HOSPITAL; PHARMACEUTICAL SOLUTIONS; STEROIDS;

EID: 0033403904     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008712422891     Document Type: Article

References (26)

1. Roland PS. Clinical ototoxicity of topical antibiotic drops. Otolaryngol Head Neck Surg 1994;110(6):598-602.
2. Hui Y, Park A, Crysdale WS, Forte V. Ototoxicity from ototopical aminoglycosides. J Otolaryngol 1997;26(1):53-6.
3. Wong DLH, Rutka JA. Do aminoglycoside otic preparations cause ototoxicity in the presence of tympanic membrane perforations? Otolaryngol Head Neck Surg 1997;116(3):404-10.
4. Linder TE, Zwicky S, Braendle P. Ototoxicity of ear drops: a clinical perspective. Am J Otol 1995;16(5):653-7.
5. Marais J, Rutka JA. Ototoxicity and topical eardrops. Clin Otolaryngol 1998;23:360-7.
6. Lundy LB, Graham MD. Ototoxicity and ototopical medications: a survey of otolaryngologists. Am J Otol 1993;14(2):141-6.
7. Kuhweide R. Experimental evidence of ototoxicity of ear drops; a review of the literature. Acta Otorhinolaryngol Belg 1995;49:293-8.
8. Rakover Y, Keywan K, Rosen G. Safety of topical ear drops containing ototoxic antibiotics. J Otolaryngol 1997;26(3):194-6.
9. Merifield DO, Parker NJ, Nicholson NC. Therapeutic management of chronic suppurative otitis media with otic drops. Otolaryngol Head Neck Surg 1993;109(1):77-82.
10. Welling DB, Forrest LA, Goll III F. Safety of ototopical antibiotics. Laryngoscope 1995;105:472-4.
11. Podoshin L, Fradis M, Ben David J. Ototoxicity of ear drops in patients suffering from chronic otitis media. J Laryngol Otol 1989;103(1):46-50.
12. Goycoolea MV, Lundman L. Round window membrane. Structure function and permeability: a review. Microsc Res Tech 1997;36:201-11.
13. Pigatto PD, Bigardi A, Legori A, Altomare G, Troiano L. Allergic contact dermatitis prevalence in patients with otitis externa. Acta Derm Venereol 1991;71(2):162-5.
14. Van Ginkel CJ, Bruintjes TD, Huizing EH. Allergy due to topical medications in chronic otitis externa and chronic otitis media. Clin Otolaryngol 1995;20(4):326-8.
15. Tange RA, Boumans LJJM, Hulst RJAM van der. Oordruppels en ototoxiciteit. Ned Tijdschr KNO heelkunde 1995;1:46-49.
16. Nederlandse Vereniging voor Keel-, Neus-, Oor-heelkunde en Heelkunde van het Hoofd-Halsgebied. Standpuntnota nr. 2: Gebruik van oordruppels met (aminoglycoside-)antibiotica en corticosteroiden bij otitis media met trommelvliesperforatie en in operatieholtes. Ned Tijdschr KNO heelkunde 1995;1:51.
17. Bluestone CD, Klein JO. Otitis media with effusion, atelectasis and eustachian tube dysfunction. In Bluestone CD, Stool SE, eds: Pediatric otolaryngology, vol.1, Philadelphia: W.B. Saunders Co. 1983.
18. Harker LA, Koontz FP. The bacteriology of cholesteatoma. In McCabe BF, Sade J, Abramson M, eds: Cholesteatoma first international conference, Birmingham, Ala: Aesculapius Publishing Co. 1977.
19. Senturia BH, Marcus MD, Lucente FE. Diseases of the external ear: an otologic-dermatologic manual. 2nd ed. New York: Grune & Stratton, 1980.
20. Morizono T, Paparella MM, Juhn SK. Ototoxicity of propylene glycol in experimental animals. Am J Otolaryngol 1980;1(5):393-9.
21. Ikeda K, Morizono T. The preparation of acetic acid for use in otic drops and its effect on endocochlear potential and pH in inner ear fluid. Am J Otolaryngol 1989;10(6):382-5.
22. Rohn GN, Meyerhoff WL, Wright CG. Ototoxicity of topical agents. Otolaryngol Clin North Am 1993;26(5):747-58.
23. Knauf HP, Silvany R, Southern PM, Risser RC, Wilson SE. Susceptibility of corneal and conjunctival pathogens to ciprofloxacin. Cornea 1996;15(1):66-71.
24. Hunter LL, Margolis RH, Rykken JR, Le CT, Daly KA, Giebink CS. High frequency hearing loss associated with otitis media. Ear Hear 1996;17:1-11.
25. Morizono T, Tono T. Middle ear inflammatory mediators and cochlear function. Otolaryngol Clin North Am 1991;24(4):835-43.
26. Morizono T. Toxicity of ototopical drugs: animal modeling. Ann Otol Rhinol Laryngol 1990;99:42-5.